Skip to content

Are There Differences in Postoperative Pain Between Bupivacaine and Lidocaine for Carpal Tunnel Release?

Which Combination of Local Anesthesia is Superior for Postoperative Pain After Carpal Tunnel Surgery?: A Prospective Randomized Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05697276
Enrollment
82
Registered
2023-01-25
Start date
2022-09-13
Completion date
2023-08-26
Last updated
2023-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel, Carpal Tunnel Syndrome

Keywords

Carpal Tunnel Syndrome, Postoperative Pain, Bupivacaine, WALANT, Lidocaine

Brief summary

The goal of this clinical trial is to compare the use of bupivacaine and lidocaine as local anesthetics in carpal tunnel release surgery. The main questions it aims to answer are: * Are there any differences in pain after surgery? * Are there any differences in postoperative analgesic consumption?

Detailed description

The Wide-Awake Local Anesthesia No Tourniquet (WALANT) technique has become popular for hand surgery in the past decade. It consists of injecting a local anesthetic and epinephrine into the surgical site. Lidocaine, a short-acting local anesthetic, is used in the classic description. Adding a long-acting local anesthetic, such as bupivacaine, has been suggested for long surgeries. However, the use of bupivacaine in shorter-duration procedures could combine the advantages of ambulatory surgery without a tourniquet with long-acting analgesia, improving postoperative pain and reducing the consumption of analgesics. Patients undergoing first-time open carpal tunnel release surgery will be randomized to receive bupivacaine or lidocaine. Randomization will be generated by computer using random block sizes of 2 or 4 with an allocation ratio of 1:1. Postoperatively, patients will receive standard medical care. It consists of 50 mg of diclofenac to take when they feel pain (with a minimum interval of 8 hours). Patients will be instructed to complete a medication log for pain and analgesic consumption. A blinded investigator will contact them by phone at 24 hours and 48hs. At two weeks, they will be controlled by research staff for complications. Eighty-two patients will be recruited, 41 per arm, assuming a 20% loss. The sample size was calculated using a 90% power and 5% significance level. The objective was to detect a minimum difference of 2 points on a numeric scale ranging from 0 to 10 with a standard deviation of 2.5 points.

Interventions

DRUGLidocaine

Patients will receive 20 ml of 1% lidocaine with 1:100,000 epinephrine (buffered 10:1 with 8.4% sodium bicarbonate). Thirty minutes before carpal tunnel release surgery, 10 mL will be injected subcutaneously, and 10 mL will be injected into the carpal tunnel.

DRUGBupivacain

Bupivacaine: Patients will receive 10 ml of 0.5% bupivacaine + 10 ml of 1% lidocaine with 1:100,000 epinephrine (buffered 10:1 with 8.4% sodium bicarbonate). Thirty minutes before carpal tunnel release surgery, 10 mL will be injected subcutaneously, and 10 mL will be injected into the carpal tunnel.

Sponsors

Hospital Italiano de Buenos Aires
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with carpal tunnel syndrome undergoing first-time surgery

Exclusion criteria

* Pregnant * End-stage kidney disease * End-stage liver disease * Allergy to bupivacaine, lidocaine or diclofenac * Carpal tunnel revision surgery * Associated surgery (e.g., trigger finger release) * Unable to understand informed consent or indications * Patients with anxiety related to surgery who explicitly prefer to be sedated or asleep during their surgery * Preoperative American Society of Anaesthesiology (ASA) scale ≥3

Design outcomes

Primary

MeasureTime frameDescription
Postoperative PainChange in pain at 24 and 48 hours or when the patients take analgesicsVisual analog scale, numerical scale from 0 to 10
Time until painUntil 48 hours from surgeryTime in hours (numeric) from surgery until the patient feel pain
Amount of analgesicat 24 and 48 hoursThe number of analgesics consumed by the patient. Numeric

Secondary

MeasureTime frameDescription
Pain during anesthesia1 minute after the injection of local anesthesiaVisual analog scale, numerical scale from 0 to 10
interruption of sleep due to painat 24 hoursDid the patient wake up because of pain the first night?, Categorical, Yes or No

Countries

Argentina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026